Kohortenstudie
Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study
Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 20-20
DOI: 10.1111/ajco.70235 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study. Asia-Pacific Journal of Clinical Oncology, 22(S6), 20-20. https://doi.org/10.1111/ajco.70235
Vancouver
Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):20-20. doi:10.1111/ajco.70235
BibTeX
@article{euvimed2026,
title = {Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {S6},
pages = {20--20},
doi = {10.1111/ajco.70235}
}
EUVIMED